(DTCK) As for home treatment of F0 in the area works efficiently, Cuu Long Pharmaceutical Joint Stock Company (DCL) donated 400,000 pills of all kinds to the Department of Health of Ho Chi Minh City to support the treatment of Covid-19 manufactured and distributed by DCL.
Particularly, Cuu Long Pharmaceutical – a member of FIT Group (FIT Group) awarded 300,000 Paracetamol 500mg tablets with the brand name Panalgan 500 and 100,000 pills of Methyl Prednisolone 16mg with the brand name m-Rednisone 16 with a total value of over 330 million dong.
These are 2 of the 5 drug categories listed by the Department of Health of Ho Chi Minh City in the prescription for adults home treatment according to Official Letter No. 5627/SYT-NVY, dated August 15, 2021 on updating “guidance on home health care packages for F0” (version 1.2).
Apart from this program, DCL incoroporated with FIT Group donated essential items and medicines in the program “FIT Group join hands to fight Covid-19” to 6 Covid treatment facilities in Ho Chi Minh City, as well as other locations. The provinces with complicated developments of the Covid-19 epidemic include: Hanoi, Bac Ninh, Bac Giang, Ha Tinh, Da Nang, Can Tho… with a total program value of over 13 billion VND.
 |
|
2 products awarded by DCL are in the category item of prescription Covid-19 home treatment instructions recently issued by the Ho Chi Minh City.Department of Health. |
Based on more than 40 years of operation experience as well as modern production lines meeting GMP-WHO standards, DCL is currently providing the market with a wide range of quality and reputable product lines through the system of 11 branches and more than 55 agents, distributors nationwide.
In the first 6 months of 2021, DCL’s consolidated profit before tax reached over VND 56.2 billion, an increase of VND 22.5 billion, equivalent to over 66% compared to the same period in 2020.
With this encouraging result, it can be said that 2021 is a breakthrough year for DCL’s profit with a revenue target of VND 805 billion, pre-tax profit of over VND 110 billion, up nearly 30% compared to 2020.
 |
Perspective of the medical equipment factory Benovas with total investment capital of over 15 million USD.
The factory is built into 2 phases, phase 1 has a designed capacity of 35 million products/month; Phase 2 has a capacity of 20 million products/month with products including: syringes, needles, infusion lines, butterfly needles, intravenous needles…
These products are manufactured on modern automation lines that meet CE standards of Europe and FDA of the United States.
After going into operation in the first quarter of 2022, the products of Benovas Medical Equipment Factory not only better meet the needs of customers, but also contribute to provide a large amount of medical equipment to the Covid-19 vaccination currently being implemented.
Besides, these products will be exported to European and US markets. Expected revenue of Benovas Medical Equipment Factory reaches VND 500 billion by 2025.
One of the highlights of DCL in 2021 is that the construction of the Benovas Medical Equipment Factory with a total investment of about 15 million USD in March.
